You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 6, June 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Paper
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Endocrine Surgery
 •Otolaryngology/ Head & Neck Surgery
 •Alert me on articles by topic

Unilateral Cervical Surgical Exploration Aided by Intraoperative Parathyroid Hormone Monitoring in Patients With Primary Hyperparathyroidism and Equivocal Sestamibi Scan Results

Richard E. Goldstein, MD, PhD; William M. Carter II, BA; Muffin Fleming, BA; Jeffrey Bumpous, MD; Eric Lentsch, MD; Michael Rice, MD; Michael Flynn, MD

Arch Surg. 2006;141:552-559.

Hypothesis  Equivocal parathyroid technetium Tc 99m sestamibi scan results are likely to demonstrate the correct location for parathyroid adenomas.

Design  Patients with primary hyperparathyroidism prospectively consented to participate in an institutional review board–approved study. The parathyroid technetium Tc 99m sestamibi scan results were classified as positive, negative, or equivocal.

Setting  A tertiary private hospital in which university faculty practice.

Patients  Technetium Tc 99m sestamibi imaging was performed for 464 patients with primary hyperparathyroidism. Eighty-four of these patients had scan results considered equivocal for unilateral adenomas. The algorithm for this group of patients specified that they should receive an injection with technetium Tc 99m sestamibi prior to parathyroidectomy and that an intraoperative parathyroid hormone (iPTH) level decrease of more than 50% be used to define intraoperative success. Seventy-two patients had postoperative calcium levels measured at least 2 weeks after their surgical procedure and defined the study group. The mean follow-up was more than 6 months.

Intervention  Parathyroidectomy.

Main Outcome Measure  Correlation of equivocal scan interpretation with operative findings and biochemical cure of hyperparathyroidism.

Results  Of the 72 patients, 39 underwent unilateral surgical explorations and 33 underwent bilateral surgical explorations; 67 (93%) of the patients were initially cured and 68 (94%) were ultimately cured. In the unilateral group, 38 (97%) of the patients were cured. The 1 failure was associated with a false-positive iPTH level decrease. In the bilateral group, 29 (88%) of the patients were initially cured and 30 (91%) were ultimately cured. Two failures were associated with a false-positive iPTH level decrease and 2 with failure to find the adenoma. Of the 33 patients in the bilateral group, surgical exploration of the opposite side was purely by surgeon choice in 11 cases. Of the other 22 patients, in addition to the 3 failures, 7 had 4-gland hyperplasia, 4 had double adenomas, and 6 had false-negative iPTH level results with iPTH level decreases of less than 50%.

Conclusion  Overall, between 48 (67%) and 54 (75%) of the 72 patients would have been cured with unilateral surgical exploration alone.


Author Affiliations: Departments of Surgery (Drs Goldstein, Bumpous, Lentsch, and Flynn, Mr Carter, and Ms Fleming) and Radiology (Dr Rice) and Center for Advanced Surgical Technology (Drs Goldstein, Bumpous, Lentsch, and Flynn, Mr Carter, and Ms Fleming), University of Louisville, Louisville, Ky.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surgery for Hyperparathyroidism in Image-Negative Patients
Chan et al.
Arch Surg 2008;143:335-337.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.